loading page

First genome sequencing of SARS-CoV-2 recovered from an infected cat and its owner in Latin America
  • +9
  • Renata Carlos,
  • Ana Paula Mariano,
  • Bianca Maciel,
  • Sandra Gadelha,
  • Mylene Silva,
  • Emilia Belitardo,
  • Danilo Rocha,
  • João Paulo Almeida,
  • Luis Gustavo Pacheco,
  • Eric Aguiar,
  • Hllytchaikra Fehlberg,
  • George Rego Albuquerque
Renata Carlos
Universidade Estadual de Santa Cruz

Corresponding Author:[email protected]

Author Profile
Ana Paula Mariano
Universidade Estadual de Santa Cruz
Author Profile
Bianca Maciel
Universidade Estadual de Santa Cruz
Author Profile
Sandra Gadelha
Universidade Estadual de Santa Cruz
Author Profile
Mylene Silva
Universidade Estadual de Santa Cruz
Author Profile
Emilia Belitardo
Universidade Federal da Bahia
Author Profile
Danilo Rocha
Universidade Federal da Bahia
Author Profile
João Paulo Almeida
Universidade Federal de Minas Gerais
Author Profile
Luis Gustavo Pacheco
Universidade Federal da Bahia
Author Profile
Eric Aguiar
Universidade Estadual de Santa Cruz
Author Profile
Hllytchaikra Fehlberg
Universidade Estadual de Santa Cruz
Author Profile
George Rego Albuquerque
Universidade Estadual de Santa Cruz
Author Profile

Abstract

An 11 years-old male mixed-breed cat, with exclusively indoor life, presented 3 cough episodes after the owners tested positive by RT-PCR for SARS-CoV-2. The house is inhabited by 5 people (3 adults and 2 children), and 2 of the adults have shown mild symptoms associated with throat discomfort. The cat was vaccinated, had no history of any previous disease, and tested negative for Feline Coronavirus (FeCoV), Feline Immunodeficiency Virus (FIV) and Feline Leukemia Virus (FeLV). Rectal sample collected from the cat was positive for SARS-CoV-2 by RT-PCR. Viral genome sequences recovered from human and cat samples showed an average 99.4% sequence identity. This is the first report of genome sequences of SARS-CoV-2 recovered from a cat and its owner in Latin America.
11 Nov 2020Submitted to Transboundary and Emerging Diseases
12 Nov 2020Submission Checks Completed
12 Nov 2020Assigned to Editor
13 Nov 2020Reviewer(s) Assigned
22 Dec 2020Review(s) Completed, Editorial Evaluation Pending
22 Dec 2020Editorial Decision: Revise Major
05 Jan 20211st Revision Received
05 Jan 2021Submission Checks Completed
05 Jan 2021Assigned to Editor
05 Jan 2021Review(s) Completed, Editorial Evaluation Pending
05 Jan 2021Editorial Decision: Accept
29 Jan 2021Published in Transboundary and Emerging Diseases. 10.1111/tbed.13984